AOD-9604 is marketed as a fat-loss fragment derived from growth hormone, positioned as lipolytic without GH side effects. What the evidence looks like: AOD-9604 has been studied in humans with a focus on safety/tolerability, including multiple randomized trials described in the literature
The method's consistency across different days and within the same day further validated its reliability
Mazumder P, Das M, Das S (2011) Butea monosperma (Lam.) Kuntze: a comprehensive review
Visible results can take some time and may vary
The research picture is the opposite: slow, cumulative, and subtle, with the biology plausibly running weeks ahead of anything observable
For both comparisons, a post hoc sensitivity analysis was performed, excluding one trial with the shortest duration and one trial with the longest duration